The Promising Effects of Lattice Radiotherapy for Large, Fungating, or Ulcerating Breast Cancers: A Prospective Single-center Study
In Vivo · 2024
DOI: 10.21873/invivo.13719 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Gianluca Ferini und 13 weiteren Autor:innen. Beteiligte Einrichtung: REM Radioterapia srl, Viagrande, Italy; gianluca.ferini@grupposamed.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Quality of Life. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: To evaluate the safety and efficacy of lattice radiotherapy (LRT) for large, inoperable breast cancers. PATIENTS AND METHODS: In this prospective study, patients who underwent LRT for breast tumors that were ulcerating/fungating/extensively eroding the chest wall, and were ineligible/unwilling for surgery, were enrolled from May 2021 to Nov 2023. Baseline Eastern Cooperative Oncology Group (ECOG) status, pre- and post-LRT numerical rating scale (NRS), and post-LRT changes in quality of life (QoL) were recorded. Survival outcomes were reported at 6 months and 1-year. Median rates of survival and dosimetric parameters were calculated. Kaplan-Meier curves for overall survival (OS), cancer-specific survival (CSS), and failure of local control (LC) were constructed. RESULTS: Ten patients (8 females) underwent LRT. The median age was 76 years (range=57-99 years) and the median ECOG performance status was 2.5 (range=1-4). The planned schedule was completed by 9/10 patients, accounting for a 90% compliance rate. Among patients with pain (n=7), NRS rapidly reduced from 7 (range=5-10) to 3 (range=1-6). The median equivalent uniform dose was 0.71 Gy (0.09-1.59 Gy). The actuarial rates of 6-month LC, CSS, and OS were 75%, 89%, and 61%, respectively, with only LC rate changing to 50% at 1 year. Two patients had local relapse at the six-month and 1-year follow-up, respectively, after having achieved a complete response at three months, and two others died of COVID-19 infection and ischemic stroke. CONCLUSION: LRT was found to be effective and safe in palliating symptoms among patients with large inoperable breast tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- REM Radioterapia srl, Viagrande, Italy; gianluca.ferini@grupposamed.com.
- Department of Medicine and Surgery, Kore University of Enna, Enna, Italy.
- REM Radioterapia srl, Viagrande, Italy.
- Department of Nursing Service, Garibaldi Hospital, Catania, Italy.
- Radiation Oncology Unit, Department of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, Messina, Italy.
- Radiation Oncology, ARNAS Civico Hospital, Palermo, Italy.
Zitieren
APA
Ferini, G., Zagardo, V., Viola, A., Patanè, D., Parisi, S., Cuccia, F., Piras, A., Fontana, P., Maugeri, G., Prestifilippo, A., Boncoraglio, A., Pontoriero, A., Harikar, M., & Pergolizzi, S. (2024). The Promising Effects of Lattice Radiotherapy for Large, Fungating, or Ulcerating Breast Cancers: A Prospective Single-center Study. In Vivo. https://doi.org/10.21873/invivo.13719
Vancouver
Ferini G, Zagardo V, Viola A, Patanè D, Parisi S, Cuccia F, et al. The Promising Effects of Lattice Radiotherapy for Large, Fungating, or Ulcerating Breast Cancers: A Prospective Single-center Study. In Vivo. 2024. doi:10.21873/invivo.13719
BibTeX
@article{Ferini2024,
author = {Ferini, Gianluca and Zagardo, Valentina and Viola, Anna and Patanè, Domenico and Parisi, Silvana and Cuccia, Francesco and Piras, Antonio and Fontana, Paolo and Maugeri, Giovanni and Prestifilippo, Angela and Boncoraglio, Andrea and Pontoriero, Antonio and Harikar, Mandara and Pergolizzi, Stefano},
title = {The Promising Effects of Lattice Radiotherapy for Large, Fungating, or Ulcerating Breast Cancers: A Prospective Single-center Study},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13719}
}
EUVIMED